{
     "PMID": "27392850",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20180129",
     "LR": "20180131",
     "IS": "1875-8908 (Electronic) 1387-2877 (Linking)",
     "VI": "53",
     "IP": "4",
     "DP": "2016 Jul 6",
     "TI": "The Anti-Prion Antibody 15B3 Detects Toxic Amyloid-beta Oligomers.",
     "PG": "1485-97",
     "LID": "10.3233/JAD-150882 [doi]",
     "AB": "15B3 is a monoclonal IgM antibody that selectively detects pathological aggregates of the prion protein (PrP). We report the unexpected finding that 15B3 also recognizes oligomeric but not monomeric forms of amyloid-beta (Abeta)42, an aggregating peptide implicated in the pathogenesis of Alzheimer's disease (AD). The 15B3 antibody: i) inhibits the binding of synthetic Abeta42 oligomers to recombinant PrP and neuronal membranes; ii) prevents oligomer-induced membrane depolarization; iii) antagonizes the inhibitory effects of oligomers on the physiological pharyngeal contractions of the nematode Caenorhabditis elegans; and iv) counteracts the memory deficits induced by intracerebroventricular injection of Abeta42 oligomers in mice. Thus this antibody binds to pathologically relevant forms of Abeta, and offers a potential research, diagnostic, and therapeutic tool for AD.",
     "FAU": [
          "Stravalaci, Matteo",
          "Tapella, Laura",
          "Beeg, Marten",
          "Rossi, Alessandro",
          "Joshi, Pooja",
          "Pizzi, Erika",
          "Mazzanti, Michele",
          "Balducci, Claudia",
          "Forloni, Gianluigi",
          "Biasini, Emiliano",
          "Salmona, Mario",
          "Diomede, Luisa",
          "Chiesa, Roberto",
          "Gobbi, Marco"
     ],
     "AU": [
          "Stravalaci M",
          "Tapella L",
          "Beeg M",
          "Rossi A",
          "Joshi P",
          "Pizzi E",
          "Mazzanti M",
          "Balducci C",
          "Forloni G",
          "Biasini E",
          "Salmona M",
          "Diomede L",
          "Chiesa R",
          "Gobbi M"
     ],
     "AD": "Department of Molecular Biochemistry and Pharmacology, IRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy. Department of Neuroscience, IRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy. Department of Molecular Biochemistry and Pharmacology, IRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy. Department of Molecular Biochemistry and Pharmacology, IRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy. Humanitas Clinical and Research Center, Rozzano (MI), Italy. Department of Life Science, University of Milan, Milan, Italy. Department of Life Science, University of Milan, Milan, Italy. Department of Neuroscience, IRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy. Department of Neuroscience, IRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy. Department of Neuroscience, IRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy. Department of Molecular Biochemistry and Pharmacology, IRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy. Department of Molecular Biochemistry and Pharmacology, IRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy. Department of Neuroscience, IRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy. Department of Molecular Biochemistry and Pharmacology, IRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.",
     "LA": [
          "eng"
     ],
     "GR": [
          "P40 OD010440/OD/NIH HHS/United States",
          "TCP14009/Telethon/Italy"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't",
          "Research Support, N.I.H., Extramural"
     ],
     "PL": "Netherlands",
     "TA": "J Alzheimers Dis",
     "JT": "Journal of Alzheimer's disease : JAD",
     "JID": "9814863",
     "RN": [
          "0 (Amyloid beta-Peptides)",
          "0 (Antibodies)",
          "0 (Peptide Fragments)",
          "0 (Prions)",
          "0 (amyloid beta-protein (1-42))"
     ],
     "SB": "IM",
     "MH": [
          "Amyloid beta-Peptides/*toxicity",
          "Animals",
          "Antibodies/*metabolism",
          "Caenorhabditis elegans",
          "Cells, Cultured",
          "Disease Models, Animal",
          "Embryo, Mammalian",
          "HEK293 Cells",
          "Hippocampus/cytology",
          "Humans",
          "Memory Disorders/chemically induced/drug therapy",
          "Mice",
          "Mice, Inbred C57BL",
          "Neurons/*drug effects/*metabolism",
          "Neurotoxicity Syndromes/etiology/*therapy",
          "Peptide Fragments/*toxicity",
          "Prions/*immunology/metabolism",
          "Protein Binding/drug effects",
          "Rats",
          "Rats, Sprague-Dawley"
     ],
     "PMC": "PMC5044783",
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "*15B3 antibody",
          "*Alzheimer's disease",
          "*amyloid beta-protein (1- 42)",
          "*oligomers",
          "*prion protein",
          "*prions"
     ],
     "EDAT": "2016/07/10 06:00",
     "MHDA": "2018/01/30 06:00",
     "CRDT": [
          "2016/07/10 06:00"
     ],
     "PHST": [
          "2016/07/10 06:00 [entrez]",
          "2016/07/10 06:00 [pubmed]",
          "2018/01/30 06:00 [medline]"
     ],
     "AID": [
          "JAD150882 [pii]",
          "10.3233/JAD-150882 [doi]"
     ],
     "PST": "ppublish",
     "SO": "J Alzheimers Dis. 2016 Jul 6;53(4):1485-97. doi: 10.3233/JAD-150882.",
     "term": "hippocampus"
}